{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:09:03Z","timestamp":1758265743071},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.genhosppsych.2005.05.012","type":"journal-article","created":{"date-parts":[[2005,9,16]],"date-time":"2005-09-16T16:40:03Z","timestamp":1126888803000},"page":"329-337","source":"Crossref","is-referenced-by-count":7,"title":["A cognitive therapy conceptualization of panic disorder exacerbated by interferon treatment"],"prefix":"10.1016","volume":"27","author":[{"given":"Guy A.","family":"Farber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomer","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig A.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2005.05.012_bib1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4088\/JCP.v64n0614","article-title":"Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy","volume":"64","author":"Kraus","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-1781(01)00315-8","article-title":"Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms","volume":"105","author":"Bonaccorso","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","article-title":"Psychometric properties of the beck depression inventory: twenty five years of evaluation","volume":"8","author":"Beck","year":"1988","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib6","series-title":"Infectious diseases","first-page":"2072","article-title":"Hepatitis C virus","author":"Raymond","year":"2004"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib7","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1002\/hep.510260711","article-title":"Epidemiology of hepatitis C","volume":"26","author":"Alter","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib8","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group","volume":"339","author":"McHutchison","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1176\/appi.psy.43.5.378","article-title":"Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C","volume":"43","author":"Fontana","year":"2002","journal-title":"Psychosomatics"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib11","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1046\/j.1365-2036.2002.01265.x","article-title":"Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C","volume":"16","author":"Kraus","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.0001-690X.2003.00230.x","article-title":"Lower activities of serum peptidases predict higher depressive and anxiety levels following interferon-alpha-based immunotherapy in patients with hepatitis C","volume":"109","author":"Maes","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1176\/appi.psy.45.1.49","article-title":"Association between apolipoprotein E epsilon4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C","volume":"45","author":"Gochee","year":"2004","journal-title":"Psychosomatics"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib14","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","article-title":"Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment","volume":"54","author":"Capuron","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","article-title":"Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system","volume":"22","author":"Bonaccorso","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0272-7358(97)00084-6","article-title":"Cognitive behavioural therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety?","volume":"18","author":"Westra","year":"1998","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1176\/ajp.154.6.773","article-title":"Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials","volume":"154","author":"Spiegel","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib18","first-page":"1","article-title":"Cognitive therapy outcomes: a review of meta-analyses","volume":"37","author":"Butler","year":"2000","journal-title":"J Norw Psychol Assoc"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00131746-200407000-00002","article-title":"Cognitive-behavioral treatment for panic disorder: current status","volume":"10","author":"Landon","year":"2004","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib20","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1192\/bjp.164.6.759","article-title":"A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder","volume":"164","author":"Clark","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1037\/0022-006X.58.1.77","article-title":"A comparison of alprazolam and behavior therapy in treatment of panic disorder","volume":"58","author":"Klosko","year":"1990","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib22","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1176\/ajp.149.6.778","article-title":"A crossover study of focused cognitive therapy for panic disorder","volume":"149","author":"Beck","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archpsyc.1993.01820130046008","article-title":"A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder","volume":"50","author":"Black","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0272-7358(95)00048-8","article-title":"A meta-analysis of treatment outcome for panic disorder","volume":"15","author":"Gould","year":"1995","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S1352465899271081","article-title":"The efficacy and cognitive processes of cognitive behaviour therapy in the treatment of panic disorder with agoraphobia","volume":"27","author":"Oei","year":"1999","journal-title":"Behav Cogn Psychother"},{"issue":"Suppl 4","key":"10.1016\/j.genhosppsych.2005.05.012_bib26","first-page":"28","article-title":"Cognitive-behavioral therapy and the treatment of panic disorder: efficacy and strategies","volume":"66","author":"Otto","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0005-7967(86)90011-2","article-title":"A cognitive approach to panic","volume":"24","author":"Clark","year":"1986","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0887-6185(97)00003-0","article-title":"Interpretive bias for benign sensations in panic disorder with agoraphobia","volume":"11","author":"Kamieniecki","year":"1997","journal-title":"J Anxiety Disord"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000063671","article-title":"Neuropsychological performance and mood states following acute interferon-beta-1b administration in healthy males","volume":"45","author":"Exton","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.genhosppsych.2005.05.012_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/0269881104040230","article-title":"Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms","volume":"18","author":"Maddock","year":"2004","journal-title":"J Psychopharmacol"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834305000745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834305000745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T15:23:30Z","timestamp":1586445810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834305000745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0163834305000745"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2005.05.012","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}